A detailed history of Intech Investment Management LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 16,673 shares of KROS stock, worth $287,775. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,673
Previous 19,099 12.7%
Holding current value
$287,775
Previous $254,000 3.54%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$13.34 - $16.05 $32,362 - $38,937
-2,426 Reduced 12.7%
16,673 $263,000
Q2 2025

Aug 08, 2025

SELL
$9.55 - $15.11 $19,319 - $30,567
-2,023 Reduced 9.58%
19,099 $254,000
Q1 2025

May 20, 2025

BUY
$10.15 - $16.1 $22,746 - $36,080
2,241 Added 11.87%
21,122 $215,000
Q4 2024

Feb 10, 2025

BUY
$15.64 - $70.0 $132,767 - $594,230
8,489 Added 81.69%
18,881 $298,000
Q3 2024

Nov 08, 2024

BUY
$41.68 - $58.07 $433,138 - $603,463
10,392 New
10,392 $603,000

Others Institutions Holding KROS

About Keros Therapeutics, Inc.


  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $445M
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.